421 related articles for article (PubMed ID: 28235596)
21. Predictors of recurrence of dysplasia or cancer in patients with dysplastic Barrett's esophagus following complete eradication of dysplasia: a single-center retrospective cohort study.
Kobayashi R; Calo NC; Marcon N; Iwaya Y; Shimamura Y; Honda H; Streutker C; Mosko J; May G; Teshima C
Surg Endosc; 2022 Jul; 36(7):5041-5048. PubMed ID: 34750708
[TBL] [Abstract][Full Text] [Related]
22. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
[TBL] [Abstract][Full Text] [Related]
23. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
[TBL] [Abstract][Full Text] [Related]
24. Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus.
Greenwald BD; Dumot JA; Horwhat JD; Lightdale CJ; Abrams JA
Dis Esophagus; 2010 Jan; 23(1):13-9. PubMed ID: 19515183
[TBL] [Abstract][Full Text] [Related]
25. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
[TBL] [Abstract][Full Text] [Related]
26. Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radiofrequency ablation.
Orman ES; Kim HP; Bulsiewicz WJ; Cotton CC; Dellon ES; Spacek MB; Chen X; Madanick RD; Pasricha S; Shaheen NJ
Am J Gastroenterol; 2013 Feb; 108(2):187-95; quiz 196. PubMed ID: 23247578
[TBL] [Abstract][Full Text] [Related]
27. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
28. A survey of expert follow-up practices after successful endoscopic eradication therapy for Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
Bedi AO; Kwon RS; Rubenstein JH; Piraka CR; Elta GH; Scheiman JM; Elmunzer BJ
Gastrointest Endosc; 2013 Nov; 78(5):696-701. PubMed ID: 23711553
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic treatment of Barrett's esophagus: From metaplasia to intramucosal carcinoma.
Chennat J; Waxman I
World J Gastroenterol; 2010 Aug; 16(30):3780-5. PubMed ID: 20698040
[TBL] [Abstract][Full Text] [Related]
31. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.
Cotton CC; Wolf WA; Overholt BF; Li N; Lightdale CJ; Wolfsen HC; Pasricha S; Wang KK; Shaheen NJ;
Gastroenterology; 2017 Sep; 153(3):681-688.e2. PubMed ID: 28579538
[TBL] [Abstract][Full Text] [Related]
32. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of Radiofrequency Ablation Compared to Liquid Nitrogen Spray Cryotherapy for the Eradication of Dysplasia in Barrett's Esophagus.
Fasullo M; Shah T; Patel M; Mutha P; Zfass A; Lippman R; Smallfield G
Dig Dis Sci; 2022 Jun; 67(6):2320-2326. PubMed ID: 33954846
[TBL] [Abstract][Full Text] [Related]
34. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients.
Dumot JA; Vargo JJ; Falk GW; Frey L; Lopez R; Rice TW
Gastrointest Endosc; 2009 Oct; 70(4):635-44. PubMed ID: 19559428
[TBL] [Abstract][Full Text] [Related]
35. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience.
Wang VS; Hornick JL; Sepulveda JA; Mauer R; Poneros JM
Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic management of high-grade dysplasia and intramucosal carcinoma: experience in a large academic medical center.
Perry KA; Walker JP; Salazar M; Suzo A; Hazey JW; Melvin WS
Surg Endosc; 2014 Mar; 28(3):777-82. PubMed ID: 24122245
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of liquid nitrogen cryotherapy for Barrett's esophagus after endoscopic resection of intramucosal cancer: A multicenter study.
Trindade AJ; Pleskow DK; Sengupta N; Kothari S; Inamdar S; Berkowitz J; Kaul V
J Gastroenterol Hepatol; 2018 Feb; 33(2):461-465. PubMed ID: 28770555
[TBL] [Abstract][Full Text] [Related]
38. Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach.
Al Natour RH; Catanzaro A; Zolotarevsky E; DeBenedet AT; Gunaratnam NT
Dis Esophagus; 2018 Jan; 31(1):1-6. PubMed ID: 29087500
[TBL] [Abstract][Full Text] [Related]
39. The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia, and Mucosal Cancer After Nissen Fundoplication.
Johnson CS; Louie BE; Wille A; Dunst CM; Worrell SG; DeMeester SR; Reynolds J; Dixon J; Lipham JC; Lada M; Peters JH; Watson TJ; Farivar AS; Aye RW
J Gastrointest Surg; 2015 May; 19(5):799-805. PubMed ID: 25740341
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.
Desai M; Saligram S; Gupta N; Vennalaganti P; Bansal A; Choudhary A; Vennelaganti S; He J; Titi M; Maselli R; Qumseya B; Olyaee M; Waxman I; Repici A; Hassan C; Sharma P
Gastrointest Endosc; 2017 Mar; 85(3):482-495.e4. PubMed ID: 27670227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
